 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Board of Directors of Medicamen Biotech Ltd at their meeting held today has allotted the 324000 (Three Lakhs Twenty Four Thousand only) Equity Shares, at a price of Rs.618/- per share including premium of Rs.608/- each ranking pari passu with the existing equity share holders of the Company.
Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs.739.8 as compared to the previous close of Rs. 744.8. The total number of shares traded during the day was 10238 in over 173 trades.
The stock hit an intraday high of Rs. 759.9 and intraday low of 725.1. The net turnover during the day was Rs. 7588307.